Meeting
2017 ASCO Annual Meeting
Checkpoint inhibitors in metastatic renal cell carcinoma patients including elderly subgroups: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
Authors
Steven Yip
University of Calgary, Calgary, AB, Canada
Steven Yip , Connor Wells , Raphael Brandao Moreira , Alex Wong , Sandy Srinivas , Benoit Beuselinck , Camillo Porta , Hao-Wen Sim , D. Scott Ernst , Brian I. Rini , Takeshi Yuasa , Naveen S. Basappa , Ravindran Kanesvaran , Lori Wood , Christina M. Canil , Anil Kapoor , Simon Yuen Fai Fu , Toni K. Choueiri , Daniel Yick Chin Heng
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 4580)
DOI
10.1200/JCO.2017.35.15_suppl.4580
Abstract #
4580
Poster Bd #
258
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Real world experience of immuno-oncology agents in metastatic renal cell carcinoma: Results from the IMDC.
First Author: Steven Yip
Poster
2019 Genitourinary Cancers Symposium
Ipilimumab plus nivolumab (Ipi/Nivo) as salvage therapy in patients with immunotherapy (IO)-refractory metastatic renal cell carcinoma (mRCC).
First Author: Anita Gul
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Use of cancer immunotherapies in the real-world in the setting of microsatellite instability.
First Author: Vineeta Agarwala
Poster
2024 ASCO Annual Meeting
Comparing rates of immune checkpoint inhibitor toxicity in different treatment settings (neoadjuvant, adjuvant, and palliative) in non-small cell lung cancer (NSCLC): A meta-analysis of phase III clinical trials.
First Author: Carolyn Moloney